Development and execution of external growth strategy:

Mepha is the leader for generic drugs in Switzerland with a market share of more than 35%. To secure further growth Mepha wanted to expand into new, but related fields by acquisitions and strategic alliances. Jointly with the management we developed the acquisition strategy, coached the laying of the of the pertaining organizational foundations and supported Mepha in the establishment of multiple strategic alliances and acquisitions in Switzerland and abroad.